Barone, Giuseppe
Barry, Ailish
Bautista, Francisco
Brichard, Bénédicte
Defachelles, Anne-Sophie
Herd, Fiona
Manzitti, Carla
Reinhardt, Dirk
Rubio, Pedro M.
Wieczorek, Aleksandra
van Noesel, Max M. http://orcid.org/0000-0003-0503-5838
Funding for this research was provided by:
eusa pharma
Article History
Accepted: 20 August 2021
First Online: 20 September 2021
Declarations
:
: The virtual advisory board meeting that led to the development of this article and editorial assistance for this article were funded by EUSA Pharma.
: GB, FB, BB, ASD, FH, CM, DR, PMR, AW and MvN received compensation for their role as a consultant/advisor at the EUSA Pharma Advisory Board meeting that has led to the subsequent development of this publication. GB has also received educational funding from EUSA Pharma. AB declares that she has no conflicts of interest that might be relevant to the contents of this article. FB had a consultant or advisory role and support for attending symposia from EUSA Pharma. ASD has received support for attending symposia from EUSA Pharma. FH has received support for attending symposia from EUSA Pharma. DR received support for attending symposia from EUSA Pharma. PMR had a consultant or advisory role and support for attending symposia from EUSA Pharma. AW has received support for attending symposia from EUSA Pharma and has a consulting agreement with EUSA Pharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors were involved in the development, review and approval of the manuscript.